Sunday, 03 July 2022

FIND, CSIR-IGIB to strengthen genomic surveillance of SARS-CoV-2 in India

06 December 2021 | News

The partnership will optimise and scale the capacity needed to identify SARS-CoV-2 variants of concern (VOC) and variants of interest (VOI)

Image Credit: Shutterstock

Image Credit: Shutterstock

FIND, the global alliance for diagnostics, has partnered with CSIR-IGIB (Institute of Genomics and Integrated Biology), New Delhi to aid India’s fight against COVID-19 by boosting sequencing capacity across the country.


The partnership aims to decentralise genomic surveillance of SARS-CoV-2, down to the district level by setting up MicroLabs that enable sequencing, analysis and interpretation of sequencing data with minimal turnaround time and infrastructure limited settings. 


As a co-lead of the Diagnostics Pillar of the Access to COVID-19 Tools (ACT) Accelerator, FIND is supporting India’s efforts towards the establishment of a robust genomic surveillance system. 


The partnership will provide strategic guidance to incorporate next-generation sequencing into broader national disease surveillance frameworks and inform data analyses, management and sharing based on global data policies and guidelines. It will provide a platform for knowledge-sharing and lessons learnt to inform national capacity-building efforts and policy guidance.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account